Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

241. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - [Qsymia] patients had improved cardiovascular and metabolic risk factors and a decrease in the need … FDA has required the manufacturer to conduct 10 postmarketing requirements, including a long-term cardiovascular … 27.0–29.9 kg/m2) with at least one obesity-related comorbidity (e.g., hypertension, dyslipidemia, cardiovascular … the-counter drugs, and herbal preparations have not been established  The effect of BELVIQ on cardiovascular … Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants

242. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - associated with an increased risk of developing MCI and Alzheimer’s disease, including depression, cancer, cardiovascular … Examples include treatment and control of chronic medical or mental health conditions (i.e., cardiovascular … Alzheimer’s disease Interventions (examples) Aspirin/nonsteroidal anti-­inflammatory drugs (NSAIDS) Cardiovascular … We will examine the treatment of diseases such as cardiovascular disease, cerebrovascular disease, hypertension

243. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Cardiovascular disease 4. Dementia (including Alzheimer’s Disease) 5. … to original research and news X Cardiology Today 1, 2, 4, 8, 9 Information source for cardiovascular … journal from the American Heart Association that publishes original medical research related to cardiovascular … Therapeutics) is the world's largest educational meeting specializing in interventional cardiovascular … information focusing on the development, sales, and marketing of major therapeutic categories - Cardiovascular

244. CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
     April 01, 2019 - that risk of deep venous thrombosis and pulmonary embolism did not vary as a function of baseline cardiovascular … another that risk of incident stroke was lower with raloxifene versus placebo in women with increased cardiovascular … -7 years reduced incident clinical and hip fractures compared with placebo, but increased risk of cardiovascular … Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis.

245. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - Discrepancies between the cardiovascular findings from the Women’s Health Initiative clinical trial … controlled trial designed to evaluate the benefits and harms of aspirin therapy in relation to preventing cardiovascular … Similarly, if a cohort study enrolled current users and compared the rate of cardiovascular events for … hypertension may be part of the mechanism through which some COX-2 therapies increase the rate of cardiovascular … Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy

246. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
     October 01, 2013 - Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … High or moderate risk patients (as defined by clinical or demographic risk factors such as age, cardiovascular … information will include abstracts from the following professional society meetings: The Trans-catheter Cardiovascular … Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular

247. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol

248. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - have a history of myocardial infarc- tion (PD � �0.7%), ischemic heart disease (PD � �1.6%), and other cardiovascular … Cardiac arrhythmia 223 1.5 Myocardial infarction 535 3.5 Other ischemic heart disease 3918 25.5 Other cardiovascular … Myocardial infarction �0.7 0.07 0.0 0.30 Other ischemic heart disease �1.6 0.09 �0.5 0.50 Other cardiovascular

249. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
     August 16, 2016 - Sum., page v, first paragraph, second sentence, "the goals of treatment are reduction in death, cardiovascular … (end of page 1) We have also added "Per expert opinion, the Society for Cardiovascular Angiography … They are later stated (more appropriately and comprehensively) to include prevention of adverse cardiovascular … Same question applies for cardiovascular events. This is a good point. … evidence that a decrease in BP by 10-20 mmHg over a long-period of time results in improvement in cardiovascular

250. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - levothyroxine therapy for subclinical hypothyroidism did not result in improved survival, decreased cardiovascular … What are the consequences of untreated subclinical thyroid disease, in particular related to cardiovascular … osteoporotic fractures • Health outcomes: quality of life, cognitive function, neuropsychiatric symptoms, cardiovascular

251. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - Celebrex NSAID Yes Hepatotoxicity; nephrotoxicity; gastritis Etodolac Lodine NSAID No Cardiovascular … Naprosyn Aleve NSAID Yes Gastritis; hepatotoxicity; nephrotoxicity Oxaprozin Daypro NSAID Yes Cardiovascular … Effects of Omega-3 Fatty Acids on Cardiovascular Disease.

252. Introduction-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/introduction-user-guide-to-ocer_130129.pdf
     April 26, 2012 - ADHD drugs and serious cardiovascular events in children and young adults. … ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

253. Association Between Outcomes and Dental Services in People at Risk of Post-Transplant Complications: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
     May 01, 2025 - Complications of Solid Organ Transplantation: Cardiovascular, Neurologic, Renal, and Gastrointestinal … Influence of Chronic Periodontitis on the Long-Term Mortality and Cardiovascular Events in Kidney Transplant … American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular … American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular … Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and

254. Covariate Selection for Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
     January 01, 2013 - For example, family history of heart disease is a measured variable indicating someone’s risk for cardiovascular … after treatment initiation (C1) is on the causal pathway between antihypertensive treatment (A0) and cardiovascular … pressure measured after the treatment was initiated (C1), because most of the medication’s effects on cardiovascular … For example, if we were interested in comparing cardiovascular events between subjects who were completely

255. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research-protocol

256. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
     June 28, 2013 - antiarrhythmic drugs, the ATHENA trial, the only study to show a reduction in the hard endpoints of cardiovascular … hospitalization and cardiovascular mortality. … Public Reviewer #1 – Edward Greissing, Sanofi Results Page 54 [p55] of the review states, “Cardiovascular … However, neither of the two references cited provides a clear definition of what constitutes a “cardiovascular … We therefore assumed all “cardiovascular hospitalizations” as listed by different authors could be

257. A Prioritized Research Agenda for Using the Harmonized Outcome Measures in the Support Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritized-research-agenda.pdf
     October 01, 2021 - conditions (e.g., anxiety, bipolar disorder) - Patients with other comorbid illnesses (e.g., cancer, cardiovascular … treatment and longer-term adverse outcomes, such as diabetes, decreased bone mineral density, and cardiovascular … antidepressant treatment and longer-term outcomes, such as diabetes, decreased bone mineral density, and cardiovascular

258. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
     June 01, 2022 - Opioids vs. no opioids, long-term harms (all-cause mortality and cardiovascular events) Opioids … associated with increased risk of all-cause mortality and cardiovascular events (myocardial infarction … or cardiovascular mortality) • SOE: low, based on 1 (all- cause mortality) or 3 (cardiovascular … Tramadol use increases mortality and risk of major adverse cardiovascular events in rheumatoid arthritis … Tramadol use increases mortality and risk of major adverse cardiovascular events in rheumatoid arthritis

259. A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
     April 20, 2022 - with pregnancies complicated by HDP have a higher risk of chronic HTN and a higher lifelong risk of cardiovascular … bold font) ● Intermediate outcomes o Blood pressure control* o Measures of end-organ function ▪ Cardiovascular … Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions … Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan.

260. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - or hypertension ▪ Infections (e.g., mastitis, wound infections) ▪ Severe maternal morbidity o Cardiovascular … coverage extension or expansion) o Presence versus absence of disorders of pregnancy (e.g., hypertensive, cardiovascular … or hypertension ▪ Infections (e.g., mastitis, wound infections) ▪ Severe maternal morbidity o Cardiovascular … coverage extension or expansion) o Presence versus absence of disorders of pregnancy (e.g., hypertensive, cardiovascular